期刊文献+

缺血修饰白蛋白及肌红蛋白在急性冠脉综合征早期的诊断意义 被引量:1

Evaluation of Ischemia Modified Albumin and Myohemoglobin in the Early Diagnosis of Acute Coronary Syndromes
下载PDF
导出
摘要 目的:评价缺血修饰白蛋白(IMA)、肌红蛋白(Mb)及心电图(ECG)对急性冠脉综合征(ACS)的早期诊断价值。方法:115例在发病6h内就诊的ACS患者,包括不稳定性心绞痛(UA组)67例和心肌梗死(MI组)48例,均行心电图检查和血清IMA、Mb水平测定,并与对照组比较各组IMA及Mb水平差异,分析IMA、Mb和ECG单项或联合诊断ACS的敏感性。结果:UA和MI两组IMA水平均明显升高,而Mb仅在MI组升高,IMA单项诊断ACS的敏感度为88.70%,明显高于Mb(51.30%)和ECG(47.83%);IMA联合ECG或Mb以及三者联合诊断ACS的敏感度高达93.04%、94.78%及97.39%,均高于单项诊断的敏感性。结论:IMA是早期诊断ACS的敏感生化指标,尤其对UA的诊断有着较高的敏感性,IMA、Mb及ECG联合检测,可进一步提高对ACS的早期诊断价值。 Objective:To evaluate the early diagnosis value of ischemia modified albumin(IMA),myohemoglobin(Mb)and ECG for acute coronary syndrome(ACS).Method:The clinical data of 115 patients and 72 healthy volunteers were analyzed.All patients were finally diagnosed to be ACS in 6 hours between 2005 and 2007.Patients with ACS were divided into 67 cases of unstable angina(UA)group and 48 cases of myocardial infarction(MI)group.ECG of 187 people were recorded and blood samples of patients with UA and MI were collected to detect the level of IMA and Mb in blood to evaluate the difference of sensitivity between combination and solitary diagnosis by IMA,Mb and ECG.Results:The level of IMA in UA and MI group were both increased,however the level of Mb were elevated only in MI group.In UA group,IMA and Mb were significantly increased.The diagnosis sensitivity of IMA was 88.70%,which was significant higher than Mb(51.30%)and ECG(47.83%).Meanwhile,the diagnosis sensitivity of IMA combined with ECG or Mb were 93.04%,94.78% and 97.39% respectively,which was much higher than that of solitary diagnosis.Conclusion:IMA may make an early diagnosis of ACS and will improve the early diagnosis sensitivity especially for the patients of UA.Meanwhile,IMA combined with ECG and Mb can further increase the early diagnosis sensitivity of ACS.
出处 《微循环学杂志》 2007年第3期55-57,共3页 Chinese Journal of Microcirculation
  • 相关文献

参考文献8

  • 1Fujimoto H, Yamaguclui T. Definition and pathophysiology of ACS. Nippon Rinsho, 2006, 64 (4): 611-616.
  • 2Defilippi C, Yoon S, Ro A, et al. Early detection of myocardial ischemia by a novel blood based biomarker. The k inetics of ischemia modified albumin. JACC, 2003, 41 (6Supp IA ): 340A.
  • 3SinhaM K, Roy D, Gaze DC, et al. Role of ischemia modified album in, a new biochem icalmarker of myocardial ischemia, in the early diagnoasis of acute coronary syndromes. EMJ, 2004, 21 (1): 29-34.
  • 4Sadler PJ, Tucker A, Viles JH. Involvement of a lysine residue in the N-terminal Ni- and Cu^2+ binding site of serum albumins. Comparison with Co^2+ , Cd^2+ and Al^3+. Eur J Biochem, 1994, 220(1) : 193-200.
  • 5Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human serum albumin cobalt assay for t he assessment of myocardial ischemia and myocardial infarction. Clin Chem, 2003, 49(4) :581- 585.
  • 6苏建友,鞠少卿,王惠民,王跃国,朱健华,陈莲英,曹金德,倪隽,尚庆毅.白蛋白钴结合试验测定缺血修饰白蛋白[J].中国交通医学杂志,2005,19(3):210-211. 被引量:23
  • 7Apple FS, Quist HE, Otto AP, et al. Release characteristics of cardiac biomarkers and ischemia- modified albumin as measured by the albumin cobalt- binding test after a marathon race. Clin Chem,2002, 48(7): 1 097-1 100.
  • 8Stejskal D, Lacna KB, Jurakoral R, et al. First experience with ecobalt binding capacity(ACB) testinthe diagnosis facute coronary syndrome(apilot study). VnitrLeK, 2004,50 (10) : 734.

二级参考文献9

  • 1Bar- Or D, Lau E, Rao N, et al. Reduction in cobalt binding capacity of human albumin with myocardial ischemia.Ann Emerg Med 1999;34(Suppl) :56.
  • 2Wu AH. The ischemia - modified albumin biomarker for myocardial ischemia. MLO Med Lab Obs 2003;35(6) :36-8,40.
  • 3Sinha MK, Roy D, Gaze DC, et al. Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004,21(1) :29-34.
  • 4Sacchetti A. "Ischemia modified albumin": a new biochemical marker of myocardial ischaemia. Emerg Med J 2004;21(1):3-4.
  • 5Christemson RH, Duh SH, Sanhai WR, et al. Characteristics of an Albumin Cobalt Binding Test for assessrnent of acute coronary syndrome patients: a multicenter study. Clin Chem 2001 ; 47(3) :464.
  • 6Sadler PJ, Tucker A, Viles JH. Involvement of a lysine residue in the N - terminal Ni and Cu binding site of serum albumins.Comparison with Co^2+ , Cd^2+ , Al^3+ . Eur J Biochern 1994;220 : 193-200.
  • 7Chan B, Dodsworth N, Woodrow J, et al. Site - specific N -terminal auto degradation of human serum albumin. Eur J Biochem 1995;227:524-528.
  • 8Alan H.B. Wu, Deborah L. Morris, Dana R. Fletcher, et al.Analysis of the albumin cobalt binding (ACB?) test as an adjunct to cardiac troponin I for the early detection of aeute myocardial Infaretion. Cardiovascular Toxicology 2001 ;01 : 147-151.
  • 9Bar- Or D, Lau E, Winkier JV. A novel assay for cobalt - albumin binding and its potential as a marker for myocardial ischernia a preliminary report. J Emerg Med 2000;19:311-315.

共引文献22

同被引文献10

  • 1苏建友,鞠少卿,王惠民,王跃国,朱健华,陈莲英,曹金德,倪隽,尚庆毅.白蛋白钴结合试验测定缺血修饰白蛋白[J].中国交通医学杂志,2005,19(3):210-211. 被引量:23
  • 2胡敏,秦立新,陈新瑞.分光光度法检测缺血性修饰白蛋白[J].中南大学学报(医学版),2005,30(4):479-480. 被引量:11
  • 3潘柏申.应重视心脏标志物的临床应用研究[J].中华检验医学杂志,2005,28(9):881-884. 被引量:56
  • 4林粼,沈晓丽.缺血修饰白蛋白的检测与临床意义[J].国际检验医学杂志,2006,27(2):131-133. 被引量:9
  • 5黄山 刘志琴 张小蓉 等.白蛋白钴结合试验测定缺血修饰性白蛋白的临床应用[J].医药世界,2006,8(6):611-611.
  • 6Morrow DA, Lemons JA, Saba tine MS, et al. The search for a biomarker of cardiacischem Clint Chen, 2003,49(4): 537- 539.
  • 7Siena MK, Gaze DC, Tip pins JP, et al. Ischemia modified albumin is agentive maker of myocardial ischemia after percutaneous coronary intervention. Circulaton, 2003,107(19) : 403-405.
  • 8Zapico Munis M, Santalo Belj, Merce Muntanola J, et al. Ischemia modified albumin is agentive maker of myocardial ischemia after percutaneous coronary intervention. Clint Chem, 2003,49 (Supple 6) :40-41.
  • 9Christenson RH, Duh SH,Sandal WR, et al. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicoated study. Clint Chem, 2001,47 (3):464.
  • 10Bar-Or-D, Lau E,Winkler JV. A novel assay for cobalt-albumin binding and its potential as marker for myocardial ischemia a preliminary. Emerge Med J,2000,19(4):311-315.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部